Publicacións nas que colabora con MARTA EUGENIA CUADROS CELORRIO (22)

2024

  1. Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma

    Molecular Cancer

2023

  1. BCL7A is silenced by hypermethylation to promote acute myeloid leukemia

    Biomarker Research, Vol. 11, Núm. 1

  2. Clinical applications of DNA methylation profiling in lung cancer

    Translational Lung Cancer Research

2022

  1. Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers

    BMC medical genomics, Vol. 15, Núm. 1, pp. 45

  2. Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma

    Clinical Epigenetics, Vol. 14, Núm. 1

  3. Opportunities of miRNAs in cancer therapeutics

    MicroRNA in Human Malignancies (Elsevier), pp. 153-164

  4. PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer

    Cellular Oncology, Vol. 45, Núm. 2, pp. 323-332

  5. Recurrent splice site mutations affect key diffuse large B-cell lymphoma genes

    Blood

2020

  1. Comprehensive analysis of SWI/SNF inactivation in lung adenocarcinoma cell models

    Cancers, Vol. 12, Núm. 12, pp. 1-14

  2. Erratum: Preoperative chemoradiotherapy for rectal cancer: The sensitizer role of the association between miR-375 and c-Myc (Oncotarget (2017) 8 (82294-82302) DOI: 10.18632/oncotarget.19393)

    Oncotarget

  3. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL

    Leukemia, Vol. 34, Núm. 10, pp. 2722-2735

  4. LncRNA DLG2-AS1 as a novel biomarker in lung adenocarcinoma

    Cancers, Vol. 12, Núm. 8, pp. 1-10

  5. Lncrna-mrna co-expression analysis identifies al133346.1/ccn2 as biomarkers in pediatric b-cell acute lymphoblastic leukemia

    Cancers, Vol. 12, Núm. 12, pp. 1-15

  6. The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma

    Oncotarget, Vol. 11, Núm. 13, pp. 1172-1185

2019

  1. Correction to: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines (Clinical and Translational Oncology, (2017), 19, 8, (1010-1017), 10.1007/s12094-017-1633-2)

    Clinical and Translational Oncology

  2. Expression of Concern: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines (Clinical and Translational Oncology, (2017), 19, 8, (1010-1017), 10.1007/s12094-017-1633-2)

    Clinical and Translational Oncology

  3. Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia

    Blood Cancer Journal

2018

  1. Long Noncoding RNAs as Cancer Biomarkers

    Cancer and Noncoding RNAs (Elsevier), pp. 95-114

2017

  1. BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines

    Clinical and Translational Oncology, Vol. 19, Núm. 8, pp. 1010-1017

2015

  1. Expression inactivation of SMARCA4 by microRNAs in lung tumors

    Human Molecular Genetics, Vol. 24, Núm. 5, pp. 1400-1409